The latest buzz in myopia treatment is the attempt to control progression in the initial stages. Atropine has been suggested by some and questioned by others. Here’s a study that tries to throw some light on the topic.

For more information: https://www.aao.org

Leave a Reply

Your email address will not be published. Required fields are marked *